Editorial commentary: pharmacokinetic variability and tuberculosis treatment outcomes, including acquired drug resistance
- PMID: 22467672
- DOI: 10.1093/cid/cis366
Editorial commentary: pharmacokinetic variability and tuberculosis treatment outcomes, including acquired drug resistance
Comment on
-
Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy.Clin Infect Dis. 2012 Jul;55(2):169-77. doi: 10.1093/cid/cis353. Epub 2012 Mar 30. Clin Infect Dis. 2012. PMID: 22467670 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical